Thrombophilia testing for women who have had pregnancy loss: clinical evidence, cost-effectiveness, and guidelines

Record ID 32015000200
Authors' recommendations: One systematic review, one non-randomized study, and five evidence-based guidelines regarding the clinical effectiveness of thrombophilia testing for women who have had early pregnancy loss were identified.
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Female
  • Adult
  • Thrombophilia
  • Prothrombin
  • Pregnancy
  • Fetal Death
  • Practice Guidelines as Topic
  • Abortion, Spontaneous
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.